Rosiglitazone: A thunderstorm from scarce and fragile data

被引：26

作者：

Mulrow, Cynthia D. ^{[1
]}

Cornell, John E. ^{[1
]}

Localio, A. Russell ^{[1
]}

机构：

[1] Amer Coll Physicians, Customer Serv, Philadelphia, PA 19106 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2007年 / 147卷 / 08期

关键词：

D O I：

10.7326/0003-4819-147-8-200710160-00013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：585 / 587

页数：3

共 13 条

[1]

Advisory Committee Briefing Document, 2007, CARD SAF ROS

[2] Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus [J].

Bolen, Shari ;

Feldman, Leonard ;

Vassy, Jason ;

Wilson, Lisa ;

Yeh, Hsin-Chieh ;

Marinopoulos, Spyriclon ;

Wiley, Crystal ;

Selvin, Elizabeth ;

Wilson, Renee ;

Bass, Eric B. ;

Brancati, Frederick L. .

ANNALS OF INTERNAL MEDICINE, 2007, 147 (06) :386-399

[3] Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events [J].

Bradburn, Michael J. ;

Deeks, Jonathan J. ;

Berlin, Jesse A. ;

Localio, A. Russell .

STATISTICS IN MEDICINE, 2007, 26 (01) :53-77

[4] Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death [J].

Diamond, George A. ;

Bax, Leon ;

Kaul, Sanjay .

ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) :578-581

[5]

FDA, 2007, JOINT M END MET DRUG

[6] Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial [J].

Gerstein, H. C. ;

Yusuf, S. ;

Holman, R. R. ;

Bosch, J. ;

Anand, S. ;

Avezum, A. ;

Budaj, A. ;

Chiasson, J. ;

Conget, I. ;

Dagenais, G. ;

Davis, M. ;

Diaz, R. ;

Dinccag, N. ;

Enjalbert, M. ;

Escalante, A. ;

Fodor, G. ;

Hanefeld, M. ;

Hedner, T. ;

Jolly, K. ;

Keltai, M. ;

Laakso, M. ;

Lanas, F. ;

Lonn, E. ;

McQueen, M. ;

Mohan, V. ;

Phillips, A. ;

Piegas, L. ;

Pirags, V. ;

Probstfield, J. ;

Shaw, J. ;

Schmid, I. ;

Teo, K. ;

Zimmet, P. ;

Zinman, B. ;

Gerstein, H. C. ;

Yusuf, S. ;

Bosch, J. ;

Pogue, J. ;

Sheridan, P. ;

Dinccag, N. ;

Hanefeld, M. ;

Hoogwerf, B. ;

Laakso, M. ;

Mohan, V. ;

Shaw, J. ;

Zinman, B. ;

Holman, R. R. ;

Diaz, R. ;

Ahuad Guerrero, R. ;

Albisu, J. .

LANCET, 2006, 368 (9541) :1096-1105

[7] Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [J].

Home, Philip D. ;

Pocock, Stuart J. ;

Beck-Nielsen, Henning ;

Gomis, Ramon ;

Hanefeld, Markolf ;

Jones, Nigel P. ;

Komajda, Michel ;

McMurray, John J. V. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :28-38

[8] Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].

Kahn, Steven E. ;

Haffner, Steven M. ;

Heise, Mark A. ;

Herman, William H. ;

Holman, Rury R. ;

Jones, Nigel P. ;

Kravitz, Barbara G. ;

Lachin, John M. ;

O'Neill, M. Colleen ;

Zinman, Bernard ;

Viberti, Giancarlo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443

[9] Coronary heart disease outcomes in patients receiving antidiabetic agents [J].

McAfee, Andrew T. ;

Koro, Carol ;

Landon, Joan ;

Ziyadeh, Najat ;

Walker, Alexander M. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (07) :711-725

[10] Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].

Nissen, Steven E. ;

Wolski, Kathy .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471

← 1 2 →